Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFP.L Regulatory News (PFP)

  • There is currently no data for PFP

Director Shareholding

4 Sep 2012 14:59

RNS Number : 4831L
Pathfinder Minerals Plc
04 September 2012
 

For immediate release: 4 September 2012

 

Pathfinder Minerals Plc

("Pathfinder Minerals" or the "Company")

 

Director's Share Purchase

 

Pathfinder Minerals was informed on 4 September 2012 that, on the same day, Nicholas Trew, the Company's Chief Executive Officer, purchased 2,300,000 ordinary shares of 1 penny each ("Ordinary Shares") in the Company, through his private pension scheme, at a price of 0.85 pence per Ordinary Share.

 

As a result of this purchase, Nicholas Trew's total interest in Pathfinder Minerals is now 92,675,753 Ordinary Shares*, equal to 8.94 per cent. of the total issued share capital.

 

*Includes 5,633,333 Ordinary Shares registered in the name of Hornbuckle Mitchell Trustees Limited and Nicholas Trew as trustees of the Private Pension - NS Trew.

 

Enquiries:

 

Pathfinder Minerals Plc

James Normand, Finance Director

Tel. +44 (0)20 7464 8412

 

Daniel Stewart & Company Plc

David Hart or James Thomas

Tel: +44 (0)20 7776 6550

 

M: Communications

Ben Simons or Maria Souvorov

Tel: +44 (0)20 7920 2340 /2327

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIMJTMBAMBLT
Date   Source Headline
22nd Feb 20237:00 amRNSUpdate re Sale of IM Minerals
2nd Feb 202311:14 amRNSHolding(s) in Company
1st Feb 20237:01 amRNSUpdate re Bilateral Investment Treaty Claim
1st Feb 20237:00 amRNSPlacing Completion and Total Voting Rights
27th Jan 20235:12 pmRNSResult of General Meeting
9th Jan 20237:00 amRNSNotice of GM
4th Jan 20237:00 amRNSUpdate re Bilateral Investment Treaty Claim
3rd Jan 20237:00 amRNSConditional Placing to Raise £0.5 Million
28th Dec 20223:44 pmRNSUpdate re Loan Agreement
8th Nov 20225:26 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
29th Sep 20227:02 amRNSLoan Agreement
29th Sep 20227:00 amRNSUpdate re Bilateral Investment Treaty Claim
30th Jun 20224:14 pmRNSResult of Annual General Meeting
17th Jun 20224:58 pmRNSNotice of AGM Explanatory Notes
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants
6th May 20223:10 pmRNSIssue of Equity and TVR
12th Apr 20227:00 amRNSCompany Strategy Update
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
4th Oct 20214:30 pmRNSGrant of Share Options
14th Sep 20217:00 amRNSHalf-year Results
19th Jul 20213:13 pmRNSChange of Registered Office
30th Jun 202111:47 amRNSResult of Annual General Meeting
29th Jun 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
24th Jun 202111:00 amRNSGrant of Share Options
9th Jun 202110:38 amRNSGrant of Share Options
7th Jun 20217:02 amRNSChange of Adviser
7th Jun 20217:01 amRNSNotice of AGM
7th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSDirector Appointment
21st May 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
12th May 20215:40 pmRNSHolding(s) in Company
12th May 202112:33 pmRNSHolding(s) in Company
4th May 20213:40 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
1st Apr 20215:58 pmRNSGrant of Share Options
1st Apr 20215:57 pmRNSHolding(s) in Company
29th Mar 20212:07 pmRNSResult of General Meeting - Replacement
29th Mar 202112:29 pmRNSResult of General Meeting
17th Mar 20217:00 amRNSDirectorate Change
10th Mar 20217:00 amRNSNotice of General Meeting
1st Mar 202110:59 amRNSChange of Auditor
19th Feb 20213:34 pmRNSStrategy Update, Placing, CLN Amendment & TVR
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.